Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral rehydration solution with short hydration to prevent cisplatin nephrotoxicity in head and neck cancer
TCTR20200207005Phase 3Recruiting
- Sponsor
- Faculty of Medicine, Prince of Songkhla University
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cisplatin in head and neck cancer (HNC), sponsored by Faculty of Medicine, Prince of Songkhla University. Started Apr 2019; status: recruiting.
02
Drugs
cisplatin
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on TCTR20200207005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200207005.